Cargando…
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
SIMPLE SUMMARY: Preoperative chemoradiotherapy (CRT) has emerged as a potential therapeutic strategy to increase the fraction of patients with pancreatic ductal adenocarcinoma (PDAC) who are candidates for surgical resection. However, treatment response is heterogeneous and ranges from complete resp...
Autores principales: | Flebbe, Hannah, Spitzner, Melanie, Marquet, Philipp Enno, Gaedcke, Jochen, Ghadimi, B. Michael, Rieken, Stefan, Schneider, Günter, Koenig, Alexander O., Grade, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908974/ https://www.ncbi.nlm.nih.gov/pubmed/35267609 http://dx.doi.org/10.3390/cancers14051301 |
Ejemplares similares
-
Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2021) -
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2014) -
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
por: Koerdel, Kristin, et al.
Publicado: (2021) -
Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
por: Flebbe, Hannah, et al.
Publicado: (2019) -
Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
por: Jo, Peter, et al.
Publicado: (2017)